DRW Securities’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$95.7K	Buy	+10,679	New	+$95.7K	﹤0.01%	885
2024 Q3	–	Sell	-11,987	Closed	-$74.1K	–	472
2024 Q2	$74.1K	Buy	+11,987	New	+$74.1K	﹤0.01%	386